Covid-19: The Vaccine Developed by Pfizer and BioNTech is “90% Effective”
The coronavirus Covid-19 vaccine candidate from both pharmaceutical companies did indeed get encouraging results after the large-scale phase 3 trial. A vaccine developed by Pfizer (United States) and BioNTech (Germany) is 90% “effective” in preventing Covid-19 infections according to the large-scale phase 3 trial underway, the last step before an application for approval, the pharmaceutical companies jointly announced. Patient protection was achieved seven […]
Continue Reading